Citius Oncology CTOR
NASDAQ CTOR
$0.98 -0.03 (-2.97%)
At close: Oct 1, 2026 · 4:00 PM EDT

Citius Oncology (CTOR) Change in Cash (2023 - 2026)

Updated

Citius Oncology's Change in Cash came in at $13.93 million for fiscal Q3 2026 (quarter ended Jun 30, 2026).

Analysis

Citius Oncology (CTOR) Change in Cash (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Citius Oncology reported Change in Cash of $12.61 million; for FY2025 (ended Sep 30, 2025), it was $3.92 million.

  • Change in Cash carries a three-year compound annual growth rate of 138.5% (FY2022 to FY2025).
  • Going back by fiscal year, Change in Cash was $112.00 in FY2024, -$256,429 in FY2023 and $289,175 in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Cash (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -1.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -2.82 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 1.49 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 739.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -2.64 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.95 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -4.45 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -727.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 649.20 Mn
10 Citius Oncology 106.82 Mn 106.82 Mn 1.00 Mn 13.93 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 13.93 Mn
Mar 31, 2026 -4.66 Mn
Dec 31, 2025 3.37 Mn
Jun 30, 2024 -33,069.00
Mar 31, 2024 584.00
Jun 30, 2023 249,719.00
Mar 31, 2023 -168,799.00
API Access

Citius Oncology Change in Cash API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-cash&ticker=CTOR&period=max&api_key=YOUR_API_KEY